Newsroom
Sorted by: Latest
-
FCPT Announces Acquisition of a United Rentals and a Buffalo Wild Wings Property for $5.4 Million
MILL VALLEY, Calif.--(BUSINESS WIRE)--Four Corners Property Trust (NYSE:FCPT), a real estate investment trust primarily engaged in the ownership and acquisition of high-quality, net-leased restaurant and retail properties (“FCPT” or the “Company”), is pleased to announce the acquisition of a United Rentals property and a Buffalo Wild Wings property for $5.4 million. The properties are located in highly trafficked corridors in Alabama and Kentucky, respectively, and corporate-operated under long...
-
Silver Bear Announces the 2025 Annual General Meeting of Shareholders Results
TORONTO--(BUSINESS WIRE)--Silver Bear Resources Plc ("Silver Bear" or the "Company") (TSX: SBR) announces the voting results of its annual general and special meeting (the “Meeting”) held today in Moscow, Russia. A total of 424,140,350 ordinary shares were voted in connection with the Meeting, representing approximately 62.53% of the issued and outstanding ordinary shares of the Company eligible to vote at the Meeting. The results of all matters considered at the Meeting are reported in the Rep...
-
Sandisk to Report Fiscal Second Quarter Results on January 29, 2026
MILPITAS, Calif.--(BUSINESS WIRE)--Sandisk Corporation (NASDAQ: SNDK) announced today that it will hold its fiscal second quarter earnings conference call on Thursday, January 29, 2026, at 1:30 p.m. Pacific Time. A live webcast and a webcast replay of the conference call will be available at investor.sandisk.com. About Sandisk Sandisk (Nasdaq: SNDK) delivers innovative Flash solutions and advanced memory technologies that meet people and businesses at the intersection of their aspirations and t...
-
CRWV Investors Have Opportunity to Join CoreWeave, Inc. Fraud Investigation with the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)--CRWV Investors Have Opportunity to Join CoreWeave, Inc. Fraud Investigation with the Schall Law Firm...
-
Biobeat Secures $50 Million Series B Financing to Advance Commercialization of its Patch-worn, Cuff-less 24-hour Ambulatory Blood Pressure Monitor
PETAH TIKVA, Israel & BOCA RATON, Fla.--(BUSINESS WIRE)--Biobeat closed a $50M Series B, led by Ally Bridge, OrbiMed, and Elevage, to expand U.S. commercialization of its 24 hour FDA-cleared ABPM....
-
Kara Wolke Recognized in the 2025 Lawdragon 500 Leading Plaintiff Financial Lawyers Guide
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray congratulates its partner Kara Wolke on being recognized in the 2025 Lawdragon 500 Leading Plaintiff Financial Lawyers Guide—a well-deserved acknowledgment of her outstanding work for investors....
-
BankUnited, Inc. to Announce Fourth Quarter and Fiscal Year 2025 Results
MIAMI LAKES, Fla.--(BUSINESS WIRE)--BankUnited, Inc. (NYSE: BKU) announced today that financial results for the quarter and fiscal year ended December 31, 2025, will be made public in a news release on Wednesday, January 21, 2026, prior to the market opening. A conference call to discuss quarterly results will be held at 9:00 a.m. ET that day with Chairman, President and Chief Executive Officer, Rajinder P. Singh, Chief Financial Officer, James G. Mackey, and Chief Operating Officer, Thomas M....
-
Equity Bancshares, Inc. Will Announce Fourth Quarter 2025 Results on January 21, 2026
WICHITA, Kan--(BUSINESS WIRE)--Equity Bancshares, Inc. (NYSE:EQBK), (“Equity”), the Wichita-based holding company of Equity Bank, will release its fourth quarter financial results on Wednesday, January 21, 2026, with a press release issued after market close. Equity Chairman and Chief Executive Officer Brad Elliott and Chief Financial Officer Chris Navratil will hold a conference call and webcast to discuss earnings results on Thursday, January 22, 2026 at 10 a.m. eastern time or 9 a.m. central...
-
Emmaus Life Sciences Announces Strategic Transaction
TORRANCE, Calif.--(BUSINESS WIRE)--Emmaus Life Sciences, Inc. (OTCQB: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today announced that it has entered into a License and Exclusive Distribution Agreement with NeoImmuneTech, Inc. (KOSDAQ:950220), or NIT, pursuant to which Emmaus has granted NIT an exclusive license to all rights to market, sell and distribute Endari® (prescription grade L-glutamine oral powder) and any generic equivalents...
-
Alcon to Present at 2026 Annual J.P. Morgan Healthcare Conference
GENEVA--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC) CEO David Endicott will present at the 2026 J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, at 8:15 a.m. PST. A live webcast of the conference will be available at investor.alcon.com/news-and-events/events-and-presentations. About Alcon Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning over 75 years, we offer the broadest portfolio of products to enhance sight and improve people’s lives. O...